GlaxoSmithKline (GSK) Consumer Healthcare will purchase Biotene, a leading dry mouth treatment, from Laclede for $170 million, the company announced. The transaction is subject to regulatory review by ...
LONDON (Reuters) - GlaxoSmithKline Plc is acquiring Biotene, a leading over-the-counter treatment for dry mouth, for $170 million in a move to bolster its consumer healthcare business. The world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback